NM_001111125.3:c.1649dupC
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001111125.3(IQSEC2):c.1649dupC(p.Leu551SerfsTer17) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001111125.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
- intellectual disability, X-linked 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe intellectual disability-progressive postnatal microcephaly- midline stereotypic hand movements syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001111125.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IQSEC2 | NM_001111125.3 | MANE Select | c.1649dupC | p.Leu551SerfsTer17 | frameshift | Exon 5 of 15 | NP_001104595.1 | ||
| IQSEC2 | NM_001441092.1 | c.1649dupC | p.Leu551SerfsTer17 | frameshift | Exon 5 of 14 | NP_001428021.1 | |||
| IQSEC2 | NM_001410736.1 | c.1649dupC | p.Leu551SerfsTer17 | frameshift | Exon 5 of 14 | NP_001397665.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IQSEC2 | ENST00000642864.1 | MANE Select | c.1649dupC | p.Leu551SerfsTer17 | frameshift | Exon 5 of 15 | ENSP00000495726.1 | ||
| IQSEC2 | ENST00000375365.2 | TSL:1 | c.1034dupC | p.Leu346SerfsTer17 | frameshift | Exon 5 of 14 | ENSP00000364514.2 | ||
| IQSEC2 | ENST00000706952.1 | c.1808dupC | p.Leu604SerfsTer17 | frameshift | Exon 5 of 15 | ENSP00000516672.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Intellectual disability, X-linked 1 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, loss-of-function variants in IQSEC2 are known to be pathogenic (PMID: 21686261, 26793055). This sequence change inserts 1 nucleotide in exon 5 of the IQSEC2 mRNA (c.1649dupC), causing a frameshift at codon 551. This creates a premature translational stop signal (p.Leu551Serfs*17) and is expected to result in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at